Suppr超能文献

美国脂肪性肝病患者的膳食补充剂使用模式:维生素、矿物质和植物药。

Patterns of dietary supplement use among United States patients with steatotic liver disease: Vitamins, minerals and botanicals.

作者信息

Wang Melinda, Jutras Gabrielle, Cullaro Giuseppe, Dhruva Anand, Lai Jennifer C

机构信息

Department of Internal Medicine, University of California San Francisco, San Francisco, CA 94143, United States.

Division of Hepatology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal H2X 0A9, Quebec, Canada.

出版信息

World J Hepatol. 2025 Mar 27;17(3):103537. doi: 10.4254/wjh.v17.i3.103537.

Abstract

BACKGROUND

Dietary supplement (DS) usage among United States adults has significantly increased. Patients with steatotic liver disease (SLD) may have unique motivations to take DS in light of their liver condition and co-morbidities.

AIM

To characterize DS use in SLD patients and explore motivations for their use.

METHODS

Adults ≥ 18 years old with complete transient elastography and dietary data from the National Health and Nutrition Examination Survey between January 2017 and March 2020 were studied. SLD was defined using consensus criteria, combining clinical indicators with elastography thresholds. The DS Questionnaire (DSQ) was used to record participants' use of DSQ. Sample weights were applied to estimate national prevalence.

RESULTS

Of 2413 participants with SLD, 1058 reported using DS, for an estimated prevalence of 44.8% [standard error (SE) 2.4] with an average of 2.6 (SE 0.2) DS per person. Among SLD participants taking DSQ, 53.2% (SE 3.3) reported using non-vitamin/non-mineral ones, with an average of 1.8 (SE 0.1) such supplements per person. DS users were more likely to be female, have higher levels of education, and have greater food security (P < 0.02 for all). The most common motivations for using DS were to follow doctor's advice (36.7%, SE 1.8), to improve overall health (22.1%, SE 2.0), and to maintain health (19.2%, SE 1.9).

CONCLUSION

Nearly half of individuals with SLD report taking DS. This study underscores the pressing need to deepen our understanding of DS use/motivations to develop tailored patient counseling strategies.

摘要

背景

美国成年人使用膳食补充剂(DS)的情况显著增加。鉴于脂肪性肝病(SLD)患者的肝脏状况和合并症,他们可能有服用DS的独特动机。

目的

描述SLD患者使用DS的情况,并探究其使用动机。

方法

对2017年1月至2020年3月期间参加美国国家健康与营养检查调查、有完整瞬时弹性成像和饮食数据的18岁及以上成年人进行研究。使用共识标准,结合临床指标和弹性成像阈值来定义SLD。采用DS问卷(DSQ)记录参与者使用DS的情况。应用样本权重来估计全国患病率。

结果

在2413名SLD参与者中,1058人报告使用DS,估计患病率为44.8%[标准误(SE)2.4],每人平均使用2.6种(SE 0.2)DS。在服用DSQ的SLD参与者中,53.2%(SE 3.3)报告使用非维生素/非矿物质DS,每人平均使用1.8种(SE 0.1)此类补充剂。DS使用者更可能为女性、受教育程度较高且粮食安全状况较好(所有P值均<0.02)。使用DS最常见的动机是听从医生建议(36.7%,SE 1.8)、改善整体健康(22.1%,SE 2.0)和维持健康(19.2%,SE 1.9)。

结论

近一半的SLD患者报告服用DS。本研究强调迫切需要加深我们对DS使用情况/动机的理解,以制定针对性的患者咨询策略。

相似文献

5
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
7
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.

本文引用的文献

6
What Should Dietary Supplement Oversight Look Like in the US?美国应该如何监管膳食补充剂?
AMA J Ethics. 2022 May 1;24(5):E402-409. doi: 10.1001/amajethics.2022.402.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验